| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/02/2011 | CN101961351A Discovery of antimicrobial activity of fish oil and application of fish oil |
| 02/02/2011 | CN101961349A Sea cucumber reinforced agglutinin and method thereof for preventing sea cucumber infective diseases |
| 02/02/2011 | CN101961348A Fute panacea |
| 02/02/2011 | CN101961343A Injection ribonucleic acid and production method thereof |
| 02/02/2011 | CN101961337A Medicinal composition with aciclovir sodium as active ingredient |
| 02/02/2011 | CN101961335A Enrofloxacin hexahydrate-containing composition and application thereof in preparing medicament for treating or preventing poultry diseases |
| 02/02/2011 | CN101961331A Ubiquitin E1 inhibitor and preparation method thereof |
| 02/02/2011 | CN101961328A Application of sodium houttuyfonate as synergist of antifungal medicament |
| 02/02/2011 | CN101961321A Zinc gluconate sugar tablet preparation and preparation method thereof |
| 02/02/2011 | CN101961313A Itraconazole nanocrystals and preparation method and application thereof |
| 02/02/2011 | CN101961178A Healthy back cushion |
| 02/02/2011 | CN101961034A Medicament for treating fish gill-rot diseases |
| 02/02/2011 | CN101721379B Cefuroxime sodium suspension powder injection |
| 02/02/2011 | CN101716153B Ornidazole ester microsphere solid preparation |
| 02/02/2011 | CN101696214B Cefminox sodium compound of new route |
| 02/02/2011 | CN101623285B Cefmetazole sodium medicament and preparation method thereof |
| 02/02/2011 | CN101623262B Cephazolin sodium pentahydrate proliposome preparation |
| 02/02/2011 | CN101623258B Ranitidine hydrochloride lipidosome capsule and new application thereof |
| 02/02/2011 | CN101612138B Cefetamet pivoxil hydrochloride capsule and preparation method thereof |
| 02/02/2011 | CN101612120B Fleroxacin freeze-dry emulsion and production method thereof |
| 02/02/2011 | CN101559108B Chinese medicinal preparation for treating beriberi, tinea corporis, tinea cruris and method for preparing same |
| 02/02/2011 | CN101502580B External-use medicament for treating tinea manus and pedis |
| 02/02/2011 | CN101491535B Method for preparing azithromycin composition with reduced bitter |
| 02/02/2011 | CN101434570B Pyrrolidine derivative, and preparation and use thereof |
| 02/02/2011 | CN101396507B Traditional Chinese medicine antibacterial liquid and preparation method and use thereof |
| 02/02/2011 | CN101396360B Medicine lotion for treating skin or scalp superficial part mycotic infection and preparation method thereof |
| 02/02/2011 | CN101343290B Preparation method for adefovir dipivoxil ester waterless crystallization article, prepared adefovir dipivoxil ester waterless crystallization article and uses thereof |
| 02/02/2011 | CN101337970B Method for synthesizing antibiotic cefpirome sulfate |
| 02/02/2011 | CN101337015B Traditional Chinese medicine for gynecology and dermatology and preparation method thereof |
| 02/02/2011 | CN101314762B Yeast engineering bacterium for expression recombination of rainbow trout antimicrobial peptide Oncorhyncin II and preparation method thereof |
| 02/02/2011 | CN101297896B Method for extracting antipyretic and detoxicated oral liquid using cellulase |
| 02/02/2011 | CN101229360B Anti-AIDS medicine |
| 02/02/2011 | CN101213193B Mono-lysine salts of azole compounds |
| 02/02/2011 | CN101212987B Self-sterilizing products |
| 02/02/2011 | CN101203246B Medical composition |
| 02/01/2011 | US7880020 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 02/01/2011 | US7879966 pH-sensitive polymer |
| 02/01/2011 | US7879872 Compositions comprising multiple bioactive agents, and methods of using the same |
| 02/01/2011 | US7879810 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines |
| 02/01/2011 | US7879366 Halogenated composition, method for preparing same and uses thereof |
| 02/01/2011 | CA2558429C Compositions and methods for preventing or treating an inflammatory response |
| 02/01/2011 | CA2555633C Non-nucleoside reverse transcriptase inhibitors |
| 02/01/2011 | CA2509554C Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors |
| 02/01/2011 | CA2481560C Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same |
| 02/01/2011 | CA2476298C Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 02/01/2011 | CA2466140C Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 02/01/2011 | CA2459449C Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 02/01/2011 | CA2454804C Probiotic lactobacillus salivarius strains |
| 02/01/2011 | CA2430755C Method of producing a partial or complete active ingredient coating on and in implants and onplants |
| 02/01/2011 | CA2418656C Proline derivatives and use thereof as drugs |
| 02/01/2011 | CA2408685C Liquid pharmaceutical composition containing an erythropoietin derivate |
| 02/01/2011 | CA2403424C Flavone derivatives, preparation method and use as medicines |
| 02/01/2011 | CA2393298C Compositions and methods for stabilizing biological molecules upon lyophilization |
| 02/01/2011 | CA2388369C Novel oligosaccharides, preparation method and pharmaceutical compositions containing same |
| 02/01/2011 | CA2382887C Immunopotentiating compositions |
| 02/01/2011 | CA2382337C Composition for treatment of infections of humans and animals |
| 02/01/2011 | CA2354508C Streptococcal c5a peptidase vaccine |
| 02/01/2011 | CA2351707C Crystal modification b of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid |
| 02/01/2011 | CA2288943C Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 02/01/2011 | CA2286385C Quinoline derivatives, having in particular antiviral properties, preparation and biological applications thereof |
| 02/01/2011 | CA2282779C Formulation comprising an antigen, an adjuvant and an amino acid for use in immunization. |
| 01/27/2011 | WO2011011303A1 Inhibitors of flaviviridae viruses |
| 01/27/2011 | WO2011010090A1 Therapeutic uses for plants of the capsicum genus |
| 01/27/2011 | WO2011010080A1 Inhibitor of inflammatory conditions |
| 01/27/2011 | WO2011010000A1 Antiviral and retroviral composition, in particular for treating aids |
| 01/27/2011 | WO2011009961A1 Combination of proteasome inhibitors and anti-hepatitis medication for treating hepatitis |
| 01/27/2011 | WO2010142956A3 Aroylthiourea and arylthiocarbonylurea derivatives |
| 01/27/2011 | WO2010138210A8 Methods of saponifying xanthophyll esters and isolating xanthophylls |
| 01/27/2011 | WO2010134100A3 Method for extraction of fractions containing pharmacologically active ingredients with less cytotoxicity from one or more plants |
| 01/27/2011 | WO2010122506A3 Meganuclease variants cleaving at least one target in the genome of a retrovirus and uses thereof |
| 01/27/2011 | WO2010112848A3 Inhibition of biofilm organisms |
| 01/27/2011 | US20110021974 Retinitis pigmentosa treatment and prophalaxis |
| 01/27/2011 | US20110021772 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 01/27/2011 | US20110021766 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation |
| 01/27/2011 | US20110021616 Halogenated rhodamine derivatives and applications thereof |
| 01/27/2011 | US20110021612 Nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 01/27/2011 | US20110021611 Efficient cell culture system for hepatitis c virus genotype 5a |
| 01/27/2011 | US20110021606 RNAi Modulation of RSV, PIV and Other Respiratory Viruses and Uses Thereof |
| 01/27/2011 | US20110021582 Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same |
| 01/27/2011 | US20110021529 P53 activating compounds |
| 01/27/2011 | US20110021513 Modulators of interleukin-1 receptor-associated kinase |
| 01/27/2011 | US20110021510 Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc) |
| 01/27/2011 | US20110021486 Viral polymerase inhibitors |
| 01/27/2011 | US20110021485 Indole derivatives and their metal conjugates and uses thereof |
| 01/27/2011 | US20110021481 Novel Compounds and Methods for Their Production |
| 01/27/2011 | US20110021473 Inhibitors of phosphodiesterase type-iv |
| 01/27/2011 | US20110021464 Methods of treating viral infections |
| 01/27/2011 | US20110021454 Modified 4`-nucleosides as antiviral agents |
| 01/27/2011 | US20110021434 Macrocyclic Cysteine Protease Inhibitors and Compositions Thereof |
| 01/27/2011 | US20110021431 Methods And Compositions For Medical Articles Produced From Proteinaceous Compounds |
| 01/27/2011 | US20110021418 Enriched haptoglobin polymers for the treatment of disease |
| 01/27/2011 | US20110021417 Compositions comprising oligosaccharides |
| 01/27/2011 | US20110021416 Compositions, methods and uses for treating bacterial infections |
| 01/27/2011 | US20110021415 Antimicrobial peptides |
| 01/27/2011 | US20110021413 Methods of suppressing microglial activation |
| 01/27/2011 | US20110020928 Immunovectors which can be used for the intracellular and intranuclear transport |
| 01/27/2011 | US20110020901 Methods of Making Viral Particles Having a Modified Cell Binding Activity and Uses Thereof |
| 01/27/2011 | US20110020480 Use of benzoxazinoids-containing cereal grain products for health-improving purposes |
| 01/27/2011 | US20110020474 Methods of Treating Infections of the Nail or Skin Using Hypohalite |
| 01/27/2011 | US20110020473 Chlorine dioxide solution composition |